Back to Search
GEOFFREY HULSE, MD
MD
Pulmonary Disease Physician
NPI: 1821060146IndividualAccepts Medicare
Specialties, Licenses & Credentials
Critical Care Medicine (Internal Medicine) Physician
Internal Medicine — Critical Care Medicine
Code: 207RC0200X
217978(NY)
Pulmonary Disease PhysicianPrimary
Internal Medicine — Pulmonary Disease
Code: 207RP1001X
217978(NY)
Education
OTHER
Class of 1997
Research & Publications (20)
The role of flumazenil in the treatment of benzodiazepine dependence: physiological and psychological profiles.
PMID 19164495·J Psychopharmacol·2009
5-case
Minor pathological changes are induced by naltrexone-poly(DL-lactide) implants in pregnant rats.
PMID 19097147·J Biomed Mater Res A·2009
7-preclinical
Assessing motivation to quit smoking in people with mental illness: a review.
PMID 19413788·Addiction·2009
4-observational
Blood naltrexone levels over time following naltrexone implant.
PMID 17651881·Prog Neuropsychopharmacol Biol Psychiatry·2008
3-trial
Smoking is associated with reduced cortical regional gray matter density in brain regions associated with incipient Alzheimer disease.
PMID 18165464·Am J Geriatr Psychiatry·2008
8-other
Biodegradability of naltrexone-poly(DL) lactide implants in vivo assessed under ultrasound in humans.
PMID 17850414·Addict Biol·2008
8-other
Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
PMID 18391134·Arch Gen Psychiatry·2008
4-observational
Mortality in heroin users 3 years after naltrexone implant or methadone maintenance treatment.
PMID 17931824·J Subst Abuse Treat·2008
4-observational
The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.
PMID 19305793·Curr Neuropharmacol·2008
8-other
Effectiveness of a smoking cessation intervention in older adults.
PMID 17207132·Addiction·2007
8-other
Mental health outcomes following naltrexone implant treatment for heroin-dependence.
PMID 17229510·Prog Neuropsychopharmacol Biol Psychiatry·2007
3-trial
Opioid overdose deaths can occur in patients with naltrexone implants.
PMID 17605708·Med J Aust·2007
8-other
A comparison of mental health hospital admissions in a cohort of heroin users prior to and after rapid opiate detoxification and oral naltrexone maintenance.
PMID 17891658·Am J Drug Alcohol Abuse·2007
4-observational
Hepatitis C virus eradication in intravenous drug users maintained with subcutaneous naltrexone implants.
PMID 17187435·Hepatology·2007
3-trial
Sustained-release naltrexone: novel treatment for opioid dependence.
PMID 17685876·Expert Opin Investig Drugs·2007
6-review
Acculturation and eating disorders in Asian and Caucasian Australian university students.
PMID 16843223·Eat Behav·2006
8-other
Eating disorder attitudes and psychopathology in Caucasian Australian, Asian Australian and Thai university students.
PMID 16476132·Aust N Z J Psychiatry·2006
8-other
Hospital morbidity and alcohol consumption in less severe psychiatric disorder: 7-year outcomes.
PMID 16738346·Br J Psychiatry·2006
4-observational
Histological changes over time around the site of sustained release naltrexone-poly(DL-lactide) implants in humans.
PMID 16154223·J Control Release·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 155 CRYSTAL RUN RD
MIDDLETOWN, NY 10941 - Phone
- (845) 703-6999
Quick Facts
- NPI
- 1821060146
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 29
- Publications
- 20
Are you this provider?
Claim Your Profile